About this trial
The purpose of this clinical trial is to determine whether targeted nutritional changes can improve symptoms of painful diabetic neuropathy. Impaired blood flow to peripheral nerves-resulting in reduced oxygen delivery and subsequent nerve injury-is a well-established contributor to neuropathy. Prior studies have shown that a whole-food, plant-based diet without added oils can improve or even reverse arterial disease, suggesting a potential mechanism for enhancing nerve perfusion and function.
This study is a randomized controlled trial comparing a whole-food, plant-based diet with standard pharmacologic management for painful diabetic neuropathy.
Eligibility criteria
Qualifiers
Definitive diagnosis of type II diabetes mellitus (HgA1c ≥ 6.5) or pre-diabetes (HgA1c 5.7-6.4)
objective documentation of peripheral neuropathy on EMG/NCS testing defined as a sural-to-radial amplitude ratio of 0.21 or less
presence of painful neuropathy in addition to decreased sensation
with pain rated ≥4/10 on a 0-10 numerical rating scale (NRS)
Disqualifiers
Potential causes of neuropathy other than type II diabetes mellitus (as listed below)
type I diabetes
vitamin B12 deficiency
folate deficiency
Trial design
Treatments tested in this trial
- Diet
- Medical management